{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:51:23Z","timestamp":1790823083178,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112956"],"award-info":[{"award-number":["70112956"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112956"],"award-info":[{"award-number":["70112956"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RE 938\/41"],"award-info":[{"award-number":["RE 938\/41"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Classification of gliomas involves the combination of histological features with molecular biomarkers to establish an integrated histomolecular diagnosis. Here, we report on the application and validation of a set of molecular assays for glioma diagnostics based on digital PCR technology using the QX200\u2122 Droplet Digital\u2122 PCR (ddPCR) system. The investigated ddPCR-based assays enable the detection of diagnostically relevant glioma-associated mutations in the\n                    <jats:italic>IDH1, IDH2, H3-3A, BRAF<\/jats:italic>\n                    , and\n                    <jats:italic>PRKCA<\/jats:italic>\n                    genes, as well as in the\n                    <jats:italic>TERT<\/jats:italic>\n                    promoter. In addition, ddPCR-based assays assessing diagnostically relevant copy number alterations were studied, including 1p\/19q codeletion, gain of chromosome 7 and loss of chromosome 10 (+\u20097\/-10),\n                    <jats:italic>EGFR<\/jats:italic>\n                    amplification, duplication of the\n                    <jats:italic>BRAF<\/jats:italic>\n                    locus, and\n                    <jats:italic>CDKN2A<\/jats:italic>\n                    homozygous deletion. Results obtained by ddPCR were validated by other methods, including immunohistochemistry, Sanger sequencing, pyrosequencing, microsatellite analyses for loss of heterozygosity, as well as real-time PCR- or microarray-based copy number assays. Particular strengths of the ddPCR approach are (1) its high analytical sensitivity allowing for reliable detection of mutations even with low mutant allele frequencies, (2) its quantitative determination of mutant allele frequencies and copy number changes, and (3) its rapid generation of results within a single day. Thus, in line with other recent studies our findings support ddPCR analysis as a valuable approach for molecular glioma diagnostics in a fast, quantitative and highly sensitive manner.\n                  <\/jats:p>","DOI":"10.1186\/s40478-022-01335-6","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:04:57Z","timestamp":1648742697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas"],"prefix":"10.1186","volume":"10","author":[{"given":"Marietta","family":"Wolter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Felsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Malzkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kaulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1419-9837","authenticated-orcid":false,"given":"Guido","family":"Reifenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/bpa.12832","volume":"30","author":"DN Louis","year":"2020","unstructured":"Louis DN, Wesseling P, Aldape K et al (2020) cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 30:844\u2013856. https:\/\/doi.org\/10.1111\/bpa.12832","journal-title":"Brain Pathol"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-020-02127-9","volume":"139","author":"DJ Brat","year":"2020","unstructured":"Brat DJ, Aldape K, Colman H et al (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol 139:603\u2013608. https:\/\/doi.org\/10.1007\/s00401-020-02127-9","journal-title":"Acta Neuropathol"},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/path.5666","volume":"254","author":"H Leske","year":"2021","unstructured":"Leske H, Dalgleish R, Lazar AJ et al (2021) A common classification framework for histone sequence alterations in tumours: an expert consensus proposal. J Pathol 254:109\u2013120. https:\/\/doi.org\/10.1002\/path.5666","journal-title":"J Pathol"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1172\/JCI33656","volume":"118","author":"S Pfister","year":"2008","unstructured":"Pfister S, Janzarik WG, Remke M et al (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118:1739\u20131749. https:\/\/doi.org\/10.1172\/JCI33656","journal-title":"J Clin Invest"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DTW Jones","year":"2008","unstructured":"Jones DTW, Kocialkowski S, Liu L et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673\u20138677. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2097","journal-title":"Cancer Res"},{"key":"1335_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0050-6","author":"R Appay","year":"2018","unstructured":"Appay R, Fina F, Macagno N et al (2018) Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-018-0050-6","journal-title":"Mod Pathol"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405. https:\/\/doi.org\/10.1007\/s00401-011-0802-6","journal-title":"Acta Neuropathol"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1038\/s41467-018-04622-w","volume":"9","author":"S Rosenberg","year":"2018","unstructured":"Rosenberg S, Simeonova I, Bielle F et al (2018) A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas. Nat Commun 9:2371. https:\/\/doi.org\/10.1038\/s41467-018-04622-w","journal-title":"Nat Commun"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41467-018-02826-8","volume":"9","author":"B Goode","year":"2018","unstructured":"Goode B, Mondal G, Hyun M et al (2018) A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nat Commun 9:810. https:\/\/doi.org\/10.1038\/s41467-018-02826-8","journal-title":"Nat Commun"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","volume":"118","author":"D Capper","year":"2009","unstructured":"Capper D, Zentgraf H, Balss J et al (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599\u2013601. https:\/\/doi.org\/10.1007\/s00401-009-0595-z","journal-title":"Acta Neuropathol"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00401-014-1337-4","volume":"128","author":"D Bechet","year":"2014","unstructured":"Bechet D, Gielen GGH, Korshunov A et al (2014) Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol 128:733\u2013741. https:\/\/doi.org\/10.1007\/s00401-014-1337-4","journal-title":"Acta Neuropathol"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-017-0449-1","volume":"5","author":"F Haque","year":"2017","unstructured":"Haque F, Varlet P, Puntonet J et al (2017) Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours. Acta Neuropathol Commun 5:45. https:\/\/doi.org\/10.1186\/s40478-017-0449-1","journal-title":"Acta Neuropathol Commun"},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2017.11.020","volume":"73","author":"H Yamamoto","year":"2018","unstructured":"Yamamoto H, Iwasaki T, Yamada Y et al (2018) Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone. Hum Pathol 73:41\u201350. https:\/\/doi.org\/10.1016\/j.humpath.2017.11.020","journal-title":"Hum Pathol"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00401-014-1370-3","volume":"129","author":"DE Reuss","year":"2015","unstructured":"Reuss DE, Sahm F, Schrimpf D et al (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an \u201cintegrated\u201d diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129:133\u2013146. https:\/\/doi.org\/10.1007\/s00401-014-1370-3","journal-title":"Acta Neuropathol"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","volume":"122","author":"D Capper","year":"2011","unstructured":"Capper D, Preusser M, Habel A et al (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122:11\u201319. https:\/\/doi.org\/10.1007\/s00401-011-0841-z","journal-title":"Acta Neuropathol"},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/neuonc\/nov289","volume":"18","author":"MN Nikiforova","year":"2016","unstructured":"Nikiforova MN, Wald AI, Melan MA et al (2016) Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. Neuro Oncol 18:379\u2013387. https:\/\/doi.org\/10.1093\/neuonc\/nov289","journal-title":"Neuro Oncol"},{"key":"1335_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00401-015-1519-8","volume":"131","author":"F Sahm","year":"2016","unstructured":"Sahm F, Schrimpf D, Jones DTW et al (2016) Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol 131:903\u2013910. https:\/\/doi.org\/10.1007\/s00401-015-1519-8","journal-title":"Acta Neuropathol"},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bpa.12367","volume":"27","author":"A Zacher","year":"2017","unstructured":"Zacher A, Kaulich K, Stepanow S et al (2017) Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel. Brain Pathol 27:146\u2013159. https:\/\/doi.org\/10.1111\/bpa.12367","journal-title":"Brain Pathol"},{"key":"1335_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"1335_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/ejh.12566","volume":"96","author":"P Gorniak","year":"2016","unstructured":"Gorniak P, Ejduk A, Borg K et al (2016) Comparison of high-resolution melting analysis with direct sequencing for the detection of recurrent mutations in DNA methyltransferase 3A and isocitrate dehydrogenase 1 and 2 genes in acute myeloid leukemia patients. Eur J Haematol 96:181\u2013187. https:\/\/doi.org\/10.1111\/ejh.12566","journal-title":"Eur J Haematol"},{"key":"1335_CR23","doi-asserted-by":"publisher","first-page":"vdaa109","DOI":"10.1093\/noajnl\/vdaa109","volume":"2","author":"MK Ball","year":"2020","unstructured":"Ball MK, Kollmeyer TM, Praska CE et al (2020) Frequency of false-positive FISH 1p\/19q codeletion in adult diffuse astrocytic gliomas. Neurooncol Adv 2:vdaa109. https:\/\/doi.org\/10.1093\/noajnl\/vdaa109","journal-title":"Neurooncol Adv"},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/CCO.0000000000000327","volume":"28","author":"B Malzkorn","year":"2016","unstructured":"Malzkorn B, Reifenberger G (2016) Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016. Curr Opin Oncol 28:494\u2013501. https:\/\/doi.org\/10.1097\/CCO.0000000000000327","journal-title":"Curr Opin Oncol"},{"key":"1335_CR25","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA et al (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604\u20138610. https:\/\/doi.org\/10.1021\/ac202028g","journal-title":"Anal Chem"},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1021\/ac403843j","volume":"86","author":"L Miotke","year":"2014","unstructured":"Miotke L, Lau BT, Rumma RT et al (2014) High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR. Anal Chem 86:2618\u20132624. https:\/\/doi.org\/10.1021\/ac403843j","journal-title":"Anal Chem"},{"key":"1335_CR27","first-page":"1065","volume":"13","author":"K Ichimura","year":"1996","unstructured":"Ichimura K, Schmidt EE, Goike HM et al (1996) Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13:1065\u20131072","journal-title":"Oncogene"},{"key":"1335_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2018.09.003","author":"B Corless","year":"2018","unstructured":"Corless B, Chang GA, Cooper S et al (2018) Development of novel mutation-specific droplet digital PCR assays detecting TERT promoter mutations in tumor and plasma samples. J Mol Diagn. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.09.003","journal-title":"J Mol Diagn"},{"key":"1335_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10014-018-0310-7","volume":"35","author":"M Hirano","year":"2018","unstructured":"Hirano M, Ohka F, Maeda S et al (2018) A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR. Brain Tumor Pathol 35:97\u2013105. https:\/\/doi.org\/10.1007\/s10014-018-0310-7","journal-title":"Brain Tumor Pathol"},{"key":"1335_CR30","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1158\/1078-0432.CCR-17-0890","volume":"23","author":"J Felsberg","year":"2017","unstructured":"Felsberg J, Hentschel B, Kaulich K et al (2017) Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified glioblastomas: prognostic role and comparison between primary and recurrent tumors. Clin Cancer Res 23:6846\u20136855. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0890","journal-title":"Clin Cancer Res"},{"key":"1335_CR31","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/ijc.28576","volume":"134","author":"M Weller","year":"2014","unstructured":"Weller M, Kaulich K, Hentschel B et al (2014) Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. Int J Cancer 134:2437\u20132447. https:\/\/doi.org\/10.1002\/ijc.28576","journal-title":"Int J Cancer"},{"key":"1335_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-020-00917-6","volume":"8","author":"M Fontanilles","year":"2020","unstructured":"Fontanilles M, Marguet F, Ruminy P et al (2020) Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma. Acta Neuropathol Commun 8:52. https:\/\/doi.org\/10.1186\/s40478-020-00917-6","journal-title":"Acta Neuropathol Commun"},{"key":"1335_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1750-3639.1999.tb00536.x","volume":"9","author":"N Ishii","year":"1999","unstructured":"Ishii N, Maier D, Merlo A et al (1999) Frequent co-alterations of TP53, p16\/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9:469\u2013479. https:\/\/doi.org\/10.1111\/j.1750-3639.1999.tb00536.x","journal-title":"Brain Pathol"},{"issue":"Suppl 1","key":"1335_CR34","first-page":"S49","volume":"29","author":"DA Armbruster","year":"2008","unstructured":"Armbruster DA, Pry T (2008) Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 29(Suppl 1):S49-52","journal-title":"Clin Biochem Rev"},{"key":"1335_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-015-1409-0","volume":"129","author":"M Weller","year":"2015","unstructured":"Weller M, Weber RG, Willscher E et al (2015) Molecular classification of diffuse cerebral WHO grade II\/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol 129:679\u2013693. https:\/\/doi.org\/10.1007\/s00401-015-1409-0","journal-title":"Acta Neuropathol"},{"key":"1335_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00401-010-0647-4","volume":"119","author":"J Felsberg","year":"2010","unstructured":"Felsberg J, Wolter M, Seul H et al (2010) Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing. Acta Neuropathol 119:501\u2013507. https:\/\/doi.org\/10.1007\/s00401-010-0647-4","journal-title":"Acta Neuropathol"},{"key":"1335_CR37","first-page":"29","volume":"58","author":"J Bostr\u00f6m","year":"1998","unstructured":"Bostr\u00f6m J, Cobbers JM, Wolter M et al (1998) Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 58:29\u201333","journal-title":"Cancer Res"},{"key":"1335_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1750-3639.2004.tb00044.x","volume":"14","author":"J Felsberg","year":"2004","unstructured":"Felsberg J, Erkwoh A, Sabel MC et al (2004) Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p\/19q status with survival. Brain Pathol 14:121\u2013130. https:\/\/doi.org\/10.1111\/j.1750-3639.2004.tb00044.x","journal-title":"Brain Pathol"},{"key":"1335_CR39","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.25448","volume":"128","author":"G Toedt","year":"2011","unstructured":"Toedt G, Barbus S, Wolter M et al (2011) Molecular signatures classify astrocytic gliomas by IDH1 mutation status. Int J Cancer 128:1095\u20131103. https:\/\/doi.org\/10.1002\/ijc.25448","journal-title":"Int J Cancer"},{"key":"1335_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ijc.21121","volume":"117","author":"P Roerig","year":"2005","unstructured":"Roerig P, Nessling M, Radlwimmer B et al (2005) Molecular classification of human gliomas using matrix-based comparative genomic hybridization. Int J Cancer 117:95\u2013103. https:\/\/doi.org\/10.1002\/ijc.21121","journal-title":"Int J Cancer"},{"key":"1335_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jmoldx.2011.07.002","volume":"13","author":"Y Tian","year":"2011","unstructured":"Tian Y, Rich BE, Vena N et al (2011) Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas. J Mol Diagn 13:669\u2013677. https:\/\/doi.org\/10.1016\/j.jmoldx.2011.07.002","journal-title":"J Mol Diagn"},{"key":"1335_CR42","doi-asserted-by":"publisher","first-page":"iii36","DOI":"10.1093\/neuonc\/nox036.130","volume":"19","author":"M Lysiak","year":"2017","unstructured":"Lysiak M, Radke K, Malmstr\u00f6m A et al (2017) P03.15 detection of 1p19q co-deletion in oligodendrogliomas with droplet digital PCR. Neuro-Oncology 19:iii36. https:\/\/doi.org\/10.1093\/neuonc\/nox036.130","journal-title":"Neuro-Oncology"},{"key":"1335_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jmoldx.2011.06.003","volume":"13","author":"I Crespo","year":"2011","unstructured":"Crespo I, Vital AL, Nieto AB et al (2011) Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. J Mol Diagn 13:634\u2013647. https:\/\/doi.org\/10.1016\/j.jmoldx.2011.06.003","journal-title":"J Mol Diagn"},{"key":"1335_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","volume":"136","author":"D Capper","year":"2018","unstructured":"Capper D, Stichel D, Sahm F et al (2018) Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol 136:181\u2013210. https:\/\/doi.org\/10.1007\/s00401-018-1879-y","journal-title":"Acta Neuropathol"},{"key":"1335_CR45","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-012-1031-3","volume":"124","author":"X-Y Liu","year":"2012","unstructured":"Liu X-Y, Gerges N, Korshunov A et al (2012) Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1\/IDH2 and TP53 mutations. Acta Neuropathol 124:615\u2013625. https:\/\/doi.org\/10.1007\/s00401-012-1031-3","journal-title":"Acta Neuropathol"},{"key":"1335_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","volume":"135","author":"DN Louis","year":"2018","unstructured":"Louis DN, Giannini C, Capper D et al (2018) cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135:639\u2013642. https:\/\/doi.org\/10.1007\/s00401-018-1826-y","journal-title":"Acta Neuropathol"},{"key":"1335_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bpa.12732","volume":"29","author":"DN Louis","year":"2019","unstructured":"Louis DN, Ellison DW, Brat DJ et al (2019) cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates. Brain Pathol 29:469\u2013472. https:\/\/doi.org\/10.1111\/bpa.12732","journal-title":"Brain Pathol"},{"key":"1335_CR48","doi-asserted-by":"publisher","first-page":"39651","DOI":"10.18632\/oncotarget.5630","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Zhao Y, Li J et al (2015) IDH1 mutation detection by droplet digital PCR in glioma. Oncotarget 6:39651\u201339660. https:\/\/doi.org\/10.18632\/oncotarget.5630","journal-title":"Oncotarget"},{"key":"1335_CR49","first-page":"230","volume":"13","author":"J Ge","year":"2020","unstructured":"Ge J, Liu MY, Li L et al (2020) Detection of IDH1 and TERT promoter mutations with droplet digital PCR in diffuse gliomas. Int J Clin Exp Pathol 13:230\u2013238","journal-title":"Int J Clin Exp Pathol"},{"key":"1335_CR50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3083","author":"K Muralidharan","year":"2020","unstructured":"Muralidharan K, Yekula A, Small JL et al (2020) TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3083","journal-title":"Clin Cancer Res"},{"key":"1335_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.579762","volume":"10","author":"R Appay","year":"2020","unstructured":"Appay R, Fina F, Barets D et al (2020) Multiplexed droplet digital PCR assays for the simultaneous screening of major genetic alterations in tumors of the central nervous system. Front Oncol 10:579762. https:\/\/doi.org\/10.3389\/fonc.2020.579762","journal-title":"Front Oncol"},{"key":"1335_CR52","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.18632\/oncotarget.12881","volume":"8","author":"F Fina","year":"2017","unstructured":"Fina F, Barets D, Colin C et al (2017) Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors. Oncotarget 8:2104\u20132113. https:\/\/doi.org\/10.18632\/oncotarget.12881","journal-title":"Oncotarget"},{"key":"1335_CR53","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-17-3800","volume":"24","author":"F Mart\u00ednez-Ricarte","year":"2018","unstructured":"Mart\u00ednez-Ricarte F, Mayor R, Mart\u00ednez-S\u00e1ez E et al (2018) Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid. Clin Cancer Res 24:2812\u20132819. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3800","journal-title":"Clin Cancer Res"},{"key":"1335_CR54","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1158\/1078-0432.CCR-20-2066","volume":"26","author":"AK Bruzek","year":"2020","unstructured":"Bruzek AK, Ravi K, Muruganand A et al (2020) Electronic DNA analysis of CSF cell-free tumor DNA to quantify multi-gene molecular response in pediatric high-grade glioma. Clin Cancer Res 26:6266\u20136276. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2066","journal-title":"Clin Cancer Res"},{"key":"1335_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.28","volume":"2","author":"WW Chen","year":"2013","unstructured":"Chen WW, Balaj L, Liau LM et al (2013) BEAMing and droplet digital PCR analysis of mutant IDH1 mRNA in glioma patient serum and cerebrospinal fluid extracellular vesicles. Mol Ther Nucleic Acids 2:e109. https:\/\/doi.org\/10.1038\/mtna.2013.28","journal-title":"Mol Ther Nucleic Acids"},{"key":"1335_CR56","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jmoldx.2017.11.009","volume":"20","author":"AC McEvoy","year":"2018","unstructured":"McEvoy AC, Wood BA, Ardakani NM et al (2018) Droplet digital PCR for mutation detection in formalin-fixed, paraffin-embedded melanoma tissues: a comparison with sanger sequencing and pyrosequencing. J Mol Diagn 20:240\u2013252. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.11.009","journal-title":"J Mol Diagn"},{"key":"1335_CR57","doi-asserted-by":"publisher","first-page":"12620","DOI":"10.1038\/s41598-019-49043-x","volume":"9","author":"V Rowlands","year":"2019","unstructured":"Rowlands V, Rutkowski AJ, Meuser E et al (2019) Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA. Sci Rep 9:12620. https:\/\/doi.org\/10.1038\/s41598-019-49043-x","journal-title":"Sci Rep"},{"key":"1335_CR58","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ccell.2019.02.007","volume":"35","author":"V K\u00f6rber","year":"2019","unstructured":"K\u00f6rber V, Yang J, Barah P et al (2019) Evolutionary trajectories of IDHWT glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis. Cancer Cell 35:692-704.e12. https:\/\/doi.org\/10.1016\/j.ccell.2019.02.007","journal-title":"Cancer Cell"},{"key":"1335_CR59","doi-asserted-by":"publisher","DOI":"10.3791\/58051","author":"C Decraene","year":"2018","unstructured":"Decraene C, Bortolini Silveira A, Michel M et al (2018) Single droplet digital polymerase chain reaction for comprehensive and simultaneous detection of mutations in hotspot regions. JoVE. https:\/\/doi.org\/10.3791\/58051","journal-title":"JoVE"},{"key":"1335_CR60","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","volume":"136","author":"DJ Brat","year":"2018","unstructured":"Brat DJ, Aldape K, Colman H et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV.\u201d Acta Neuropathol 136:805\u2013810. https:\/\/doi.org\/10.1007\/s00401-018-1913-0","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01335-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:07:19Z","timestamp":1648742839000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01335-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01335-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"18 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"42"}}